You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › February › 07
Hims
5 months ago
The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.
US announces crackdown on copycat weight-loss drugs ○
found
a story from Financial Times ✅ › Financial Times
Food and Drug Administration targets Hims & Hers after telehealth company undercuts Novo Nordisk on obesity shot
page 1 of 1